Flywire (FLYW - Free Report) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +100.00%. A quarter ago, it was expected that this payments company would post earnings of $0.19 per share when it actually produced earnings of $0.23, delivering a surprise of +21.05%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Flywire, which belongs to the Zacks Internet - Software industry, posted revenues of $152.7 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 6.17%. This compares to year-ago revenues of $112.8 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Flywire shares have lost about 24.9% since the beginning of the year versus the S&P 500's decline of 0.1%.
What's Next for Flywire?While Flywire has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Flywire was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.02 on $154.41 million in revenues for the coming quarter and $0.28 on $686.21 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
PubMatic, Inc. (PUBM - Free Report) , another stock in the same industry, has yet to report results for the quarter ended December 2025. The results are expected to be released on February 26.
This company is expected to post quarterly earnings of $0.16 per share in its upcoming report, which represents a year-over-year change of -61%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
PubMatic, Inc.'s revenues are expected to be $75.11 million, down 12.2% from the year-ago quarter.
Evolent Health (EVH - Free Report) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.02 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +28.00%. A quarter ago, it was expected that this health care software and consulting services provider would post earnings of $0.1 per share when it actually produced earnings of $0.05, delivering a surprise of -50%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Evolent Health, which belongs to the Zacks Medical Info Systems industry, posted revenues of $468.72 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 0.11%. This compares to year-ago revenues of $646.54 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Evolent Health shares have lost about 30.8% since the beginning of the year versus the S&P 500's decline of 0.1%.
What's Next for Evolent Health?While Evolent Health has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Evolent Health was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.08 on $544.44 million in revenues for the coming quarter and $0.39 on $2.39 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Info Systems is currently in the bottom 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, KORU Medical Systems, Inc. (KRMD - Free Report) , has yet to report results for the quarter ended December 2025.
This company is expected to post quarterly loss of $0.02 per share in its upcoming report, which represents a year-over-year change of +33.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
KORU Medical Systems, Inc.'s revenues are expected to be $10.89 million, up 23.2% from the year-ago quarter.
2026-02-25 04:152mo ago
2026-02-24 22:552mo ago
Everus Construction Group, Inc. (ECG) Q4 Earnings and Revenues Top Estimates
Everus Construction Group, Inc. (ECG - Free Report) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.67 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +51.05%. A quarter ago, it was expected that this company would post earnings of $0.62 per share when it actually produced earnings of $1.11, delivering a surprise of +79.03%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Everus Construction Group, Inc., which belongs to the Zacks Building Products - Miscellaneous industry, posted revenues of $1.01 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 20.45%. This compares to year-ago revenues of $759.64 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Everus Construction Group, Inc. shares have added about 24% since the beginning of the year versus the S&P 500's decline of 0.1%.
What's Next for Everus Construction Group, Inc.?While Everus Construction Group, Inc. has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Everus Construction Group, Inc. was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.70 on $889.31 million in revenues for the coming quarter and $3.79 on $3.84 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Building Products - Miscellaneous is currently in the bottom 31% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Southland Holdings (SLND - Free Report) , has yet to report results for the quarter ended December 2025.
This infrastructure construction company is expected to post quarterly loss of $0.21 per share in its upcoming report, which represents a year-over-year change of -133.3%. The consensus EPS estimate for the quarter has been revised 289.7% lower over the last 30 days to the current level.
Southland Holdings' revenues are expected to be $210.9 million, down 21.1% from the year-ago quarter.
2026-02-25 04:152mo ago
2026-02-24 22:552mo ago
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates
AbCellera Biologics Inc. (ABCL - Free Report) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.11 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +83.56%. A quarter ago, it was expected that this company would post a loss of $0.17 per share when it actually produced a loss of $0.19, delivering a surprise of -11.76%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
ABCELLERA BIOLG, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $44.85 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 565.48%. This compares to year-ago revenues of $5.05 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
ABCELLERA BIOLG shares have lost about 11.4% since the beginning of the year versus the S&P 500's decline of 0.1%.
What's Next for ABCELLERA BIOLG?While ABCELLERA BIOLG has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for ABCELLERA BIOLG was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.16 on $16.81 million in revenues for the coming quarter and -$0.67 on $57.07 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 37% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, CytomX Therapeutics (CTMX - Free Report) , has yet to report results for the quarter ended December 2025.
This biopharmaceutical company is expected to post quarterly loss of $0.08 per share in its upcoming report, which represents a year-over-year change of -136.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
CytomX Therapeutics' revenues are expected to be $7.35 million, down 80.7% from the year-ago quarter.
2026-02-25 04:152mo ago
2026-02-24 22:552mo ago
Carlyle Secured Lending, Inc. (CGBD) Q4 Earnings and Revenues Miss Estimates
Carlyle Secured Lending, Inc. (CGBD - Free Report) came out with quarterly earnings of $0.33 per share, missing the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -12.23%. A quarter ago, it was expected that this company would post earnings of $0.39 per share when it actually produced earnings of $0.38, delivering a surprise of -2.56%.
Over the last four quarters, the company has not been able to surpass consensus EPS estimates.
Carlyle Secured Lending, which belongs to the Zacks Financial - SBIC & Commercial Industry industry, posted revenues of $41.46 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 9.03%. This compares to year-ago revenues of $39.23 million. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Carlyle Secured Lending shares have lost about 11.1% since the beginning of the year versus the S&P 500's decline of 0.1%.
What's Next for Carlyle Secured Lending?While Carlyle Secured Lending has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Carlyle Secured Lending was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.37 on $45.72 million in revenues for the coming quarter and $1.48 on $183.66 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Financial - SBIC & Commercial Industry is currently in the bottom 44% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Stellus Capital (SCM - Free Report) , is yet to report results for the quarter ended December 2025.
This investment company is expected to post quarterly earnings of $0.31 per share in its upcoming report, which represents a year-over-year change of -16.2%. The consensus EPS estimate for the quarter has been revised 1.7% lower over the last 30 days to the current level.
Stellus Capital's revenues are expected to be $26.06 million, up 1.7% from the year-ago quarter.
2026-02-25 04:152mo ago
2026-02-24 22:552mo ago
CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates
CeriBell, Inc. (CBLL - Free Report) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.4 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +16.76%. A quarter ago, it was expected that this company would post a loss of $0.43 per share when it actually produced a loss of $0.37, delivering a surprise of +13.95%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
CeriBell, Inc., which belongs to the Zacks Medical - Products industry, posted revenues of $24.78 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 4.40%. This compares to year-ago revenues of $18.53 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
CeriBell, Inc. shares have lost about 8.9% since the beginning of the year versus the S&P 500's decline of 0.1%.
What's Next for CeriBell, Inc.?While CeriBell, Inc. has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for CeriBell, Inc. was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.37 on $26.01 million in revenues for the coming quarter and -$1.46 on $112.76 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Products is currently in the bottom 45% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Agilent Technologies (A - Free Report) , has yet to report results for the quarter ended January 2026. The results are expected to be released on February 25.
This scientific instrument maker is expected to post quarterly earnings of $1.37 per share in its upcoming report, which represents a year-over-year change of +4.6%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Agilent Technologies' revenues are expected to be $1.8 billion, up 7.3% from the year-ago quarter.
2026-02-25 04:152mo ago
2026-02-24 22:552mo ago
Archrock Inc. (AROC) Q4 Earnings and Revenues Beat Estimates
Archrock Inc. (AROC - Free Report) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.35 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +73.94%. A quarter ago, it was expected that this natural gas compression services business would post earnings of $0.41 per share when it actually produced earnings of $0.42, delivering a surprise of +2.44%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Archrock Inc., which belongs to the Zacks Oil and Gas - Field Services industry, posted revenues of $377.07 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.11%. This compares to year-ago revenues of $326.42 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Archrock Inc. shares have added about 26.1% since the beginning of the year versus the S&P 500's decline of 0.1%.
What's Next for Archrock Inc.?While Archrock Inc. has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Archrock Inc. was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #1 (Strong Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.46 on $385.04 million in revenues for the coming quarter and $1.94 on $1.58 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Oil and Gas - Field Services is currently in the top 36% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, ProFrac Holding Corp. (ACDC - Free Report) , is yet to report results for the quarter ended December 2025.
This company is expected to post quarterly loss of $0.44 per share in its upcoming report, which represents a year-over-year change of +30.2%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
ProFrac Holding Corp.'s revenues are expected to be $390.03 million, down 14.2% from the year-ago quarter.
Seagate has been re-rated in the last 6 months as an AI data center infrastructure bet in the HDD memory space. Perception changed, but revenue growth is still far from Micron and SanDisk, as HDD is seeing fewer price hikes than SSDs or DRAM/HBM chips. That said, STX delivered its highest free cash flow in eight years and guided above consensus, with 87% of exabyte shipments now data center-driven.
2026-02-25 04:152mo ago
2026-02-24 22:572mo ago
MercadoLibre, Inc. (MELI) Q4 2025 Earnings Call Transcript
Amplitude Energy Limited (COPJF) Q2 2026 Earnings Call February 24, 2026 5:00 PM EST
Company Participants
Jane Norman - MD, CEO & Director
Ian Bucknell - Chief Financial Officer
Chad Wilson - Chief Operating Officer
Conference Call Participants
Gordon Ramsay - RBC Capital Markets, Research Division
Dale Koenders - Barrenjoey Markets Pty Limited, Research Division
Nik Burns - Jarden Limited, Research Division
James Bullen - Canaccord Genuity Corp., Research Division
Declan Bonnick - Euroz Hartleys Securities Limited, Research Division
Presentation
Operator
Welcome to the Amplitude Energy Limited FY '26 First Half Results Webcast. [Operator Instructions]
I will now pass over to Jane Norman, Managing Director and Chief Executive Officer of Amplitude Energy. Please go ahead, Jane.
Jane Norman
MD, CEO & Director
Good morning, and thank you for joining us. This is Jane Norman, and I'm joined today by our Chief Operating Officer, Chad Wilson; and our new Chief Financial Officer, Ian Bucknell.
For those who haven't yet met Ian, he started with Amplitude as our CFO in January this year. Ian has held several prior CFO roles at ASX-listed energy and mining companies over the last 15 years, and we are very pleased to have someone of his caliber add to the strength of the executive team. Ian will cover our first half financial results in detail a little later on.
After today's presentation, we will host a Q&A session, and we welcome your questions. Today's presentation as well as our first half financial report and summary announcement were released to the ASX this morning and are available on the Amplitude Energy website. Today's webcast is being recorded, and a playback will be available on our website later today.
Please note the disclaimer information on Slide 2 of the presentation before moving on to Slide 3.
I'll come to our record first half
2026-02-25 04:152mo ago
2026-02-24 23:072mo ago
Metalpha, Exos Financial, and BlockchainK2 Announce Joint Venture for US Institutional Digital Asset Market
, /PRNewswire/ -- Metalpha Technology Holding Limited (NASDAQ: MATH) ("Metalpha"), a global leading provider of blockchain and trading technology solutions, today announced the signing of a Memorandum of Understanding ("MOU") with Exos Financial LLC ("Exos"), a technology-driven boutique financial services platform based in New York, and BlockchainK2 Corp. (TSXV: BITK) ("BK2"), a public Canadian holding company for blockchain technology companies. The three parties intend to form a Joint Venture ("JV") aimed at delivering compliant, institutional-grade digital asset solutions to clients based primarily in the United States.
The proposed Joint Venture unites three highly complementary industry leaders to address the growing demand for crypto-financial services in the US. This strategic collaboration leverages Metalpha's deep expertise in cryptocurrency derivatives and liquidity solutions alongside Exos Financial's regulated investment banking and asset management businesses and framework, established by former Credit Suisse CEO Brady Dougan. Completing the ecosystem, BlockchainK2 contributes advanced technology platforms for tokenization and fund distribution through its portfolio interests, effectively bridging the gap between traditional finance and digital assets.
Under the terms of the MOU, the parties plan to establish a business dedicated to delivering digital asset solutions to primarily the US institutional market, focusing initially on three core pillars: offering tailored OTC derivatives and hedging solutions to institutions and miners; developing digital asset investment strategies, such as crypto relative value; and creating securities-linked transactions that provide exposure to digital assets.
"This partnership represents a significant milestone in Metalpha's global expansion strategy," said Mr. Adrian Wang, CEO of Metalpha. "By joining forces with Exos and BlockchainK2, we are positioning ourselves to enter the critical US market with a fully compliant, institutional-grade offering. We look forward to leveraging Exos's extensive knowledge and experience in the US market and BK2's technological infrastructure to bring our market-leading derivative products to US clients."
"At Exos, we believe the future of finance lies in the seamless integration of technology and compliance," said Brady Dougan, Founder and CEO of Exos Financial. "Partnering with Metalpha and BlockchainK2 allows us to extend our modern institutional platform into the digital asset space, offering clients sophisticated strategies with the infrastructure and support they expect from a top-tier financial institution."
"We are excited to facilitate this venture," said Sergei Stetsenko, CEO of BlockchainK2. "The combination of Metalpha's trading prowess, Exos's institutional pedigree, and our ecosystem's technological capabilities creates a powerful engine for growth. This JV is designed to solve key pain points for US institutions seeking exposure to digital assets."
About Metalpha
Metalpha Technology Holding Limited (NASDAQ: MATH) is a global leading provider of blockchain and trading technology solutions. With extensive blockchain and traditional fintech expertise, we are dedicated to delivering state-of-the-art technological solutions, including digital asset related management systems, hedging infrastructures, liquidity solutions and institutional grade architectures. We offer highly customized, one-stop solutions to help our customers grow their businesses and are committed to strengthening our position as one of the largest gateways to digital assets in Asia.
About Exos Financial LLC
Founded in 2018, Exos Financial is a B2B institutional finance platform designed to modernize the delivery of investment banking and wealth management services. Exos operates U.S. regulated entities, offering technology-driven solutions in investment banking, asset management, and alternative investments.
About BlockchainK2 Corp.
BlockchainK2 Corp. (TSXV: BITK; OTCQB: BIDCF; GERMANY: KRL2) is a holding company investing in blockchain technology solutions for capital markets and other sectors. The Company owns a majority interest in RealBlocks, a technology platform for private equity, private credit, and real estate that provides tokenized secondary trading and fund distribution solutions.
Forward-Looking Statements
This press release contains statements that may constitute "forward-looking" statements pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to" and similar statements. Management has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While they believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond management's control. These statements involve risks and uncertainties that may cause Metalpha's actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements.
SOURCE Metalpha Technology Holding Ltd.
2026-02-25 04:152mo ago
2026-02-24 23:082mo ago
TBC Bank Group PLC (TBCCF) Strategy Day: Discusses Group Strategic Plans and Regional Focus on Georgia and Uzbekistan Transcript
Agora is transitioning from audio/video services to a leading Conversational AI Infrastructure provider, leveraging its proprietary SD-RTN network and AI Engine 2.0. API achieved its fourth consecutive quarter of revenue growth, posting $35.4 million in Q3 with 12% YoY growth and a return to net profitability. Significant restructuring improved operational efficiency, reducing R&D to 39% of revenue and administrative expenses by half, while maintaining $374 million in liquidity.
2026-02-25 04:152mo ago
2026-02-24 23:122mo ago
Abbott Cooper PLLC Investigates Potential Breaches of Fiduciary Duty by Lee Enterprises, Incorporated Board of Directors
STAMFORD, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating potential breaches of fiduciary duty by the Board of Directors of Lee Enterprises, Incorporated (Nasdaq: LEE) on behalf of the company's stockholders.
The investigation focuses on whether the Lee Enterprises Board of Directors has fulfilled its fiduciary obligations to stockholders, including its duty of loyalty.
Stockholders who have held shares of Lee Enterprises and are interested in learning more about the investigation or their legal rights are encouraged to contact Abbott Cooper PLLC at no cost or obligation.
Abbott Cooper PLLC handles cases on a contingency fee basis, meaning there is no cost to stockholders unless a recovery is obtained.
IF YOU ARE A LEE ENTERPRISES STOCKHOLDER AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, PLEASE CONTACT:
J. Abbott R. Cooper
Abbott Cooper PLLC
1266 East Main Street
Suite 700R
Stamford, CT 06902
(475) 477-5031 [email protected]
https://abbottlawyer.com/
Attorney Advertising. Prior results do not guarantee a similar outcome.
2026-02-25 03:152mo ago
2026-02-24 21:172mo ago
ARDT UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Ardent Health (ARDT) Investors of Securities Class Action Deadline on April 21, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - February 24, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT) and reminds investors of the April 21, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: During the Class Period, Defendants publicly reported the Company's accounts receivable on a quarterly basis. They further stated that Ardent Health employed an active monitoring process to determine the collectability of its accounts receivable, and that this process included "detailed reviews of historical collections" as a "primary source of information." Further, Defendants represented that Ardent Health considered "trends in federal and state governmental healthcare coverage" and that its "management determines [when an] account is uncollectible, at which time the account is written off
On November 12, 2025, after market hours, Ardent Health revealed a $43 million decrease in third quarter 2025 revenue. The decrease resulted from revised determinations of accounts receivable collectability after the Company transitioned to a new revenue accounting system and from purported "recently completed hindsight evaluations of historical collection trends." The new system-called the Kodiak RCA net revenue platform-provided management with "additional information to more precisely" determine accounts receivable collectability, including "more timely consideration of payor denial and payment trends." Defendant Lumsdaine revealed that the new system "recognizes reserves earlier in an account's life cycle" compared to the Company's prior -5- collectability framework, which "had utilized a 180-day cliff at which time an account became fully reserved."
Ardent Health also announced a cut to 2025 EBITDA guidance of $57.5 million at the midpoint, or about 9.6%, from $575 million - $625 million to $530 million - $555 million because of "persistent industry-wide cost pressures," including "payer denials." In addition, Ardent Health recorded a $54 million increase in professional liability reserves "with respect to recent settlements and ongoing litigation arising from a limited set of claims between 2019 and 2022 in New Mexico" as well as "consideration of broader industry trends, including social inflationary pressures."
On this news, the price of Ardent Health stock fell $4.75 per share, or nearly 34%,
from $14.05 per share on November 12, 2025, to close at $9.30 per share on November 13, 2025,
on unusually heavy trading volume.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Ardent's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Ardent Health class action, go to www.faruqilaw.com/ARDT or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/285105
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Contact Us
2026-02-25 03:152mo ago
2026-02-24 21:182mo ago
Are the Signs Pointing to Another Nasdaq-100 Correction?
At some point in 2024, market sentiment began to shift. Even though the Nasdaq-100 was continuing to set new all-time highs, the number of stocks trading above their 200-day moving average declined pretty steadily from January all the way through December. The trend was fairly intuitive at the time, because we knew that the "Magnificent Seven" stocks were almost single-handedly pulling the major averages higher.
In hindsight, that trend was interesting because it preceded a more than 20% correction for the index related to President Donald Trump's "Liberation Day" tariffs.
This same story also played out in 2021. The Nasdaq-100 and the Invesco QQQ ETF (QQQ +1.07%) that tracks it were in a furious bull market ascent as the economy was recovering from the COVID-19 pandemic shutdowns, thanks to a multitrillion-dollar stimulus package from the U.S. government. The index spent most of the year moving higher, with just a few bumps along the way.
But just like in 2024, the number of stocks in the index trading above their 200-day moving average was decreasing. In March of that year, roughly 90% of the components were trading above their 200-day moving average. By Christmas, it was closer to 50%.
Image source: Getty Images.
What happened next was the start of the 2022 bear market that was fueled by soaring inflation and a Fed that was far too slow to respond to what was happening. In this case, the Nasdaq-100 fell by more than 30% from peak to valley.
Today, we're approaching a similar scenario.
After bouncing off the "Liberation Day" low in April, U.S. equity prices spent the remainder of 2025 pushing consistently higher. But the number of stocks trading above their 200-day moving average peaked during the second quarter of the year and has been moving lower ever since.
If this pattern remains intact, does that mean another 20% correction is nearing?
The path of returns in these past situations is somewhat understandable. It suggests that rising market averages are being supported by fewer and fewer stocks. Then, when those handful of leaders finally crack, the index goes tumbling with it.
What about this time? The same thing seems to be happening again. In 2025, only three sectors outperformed the S&P 500 (^GSPC +0.77%). Two of them were technology and communication services -- in other words, the home of the "Magnificent Seven" stocks. Where do a lot of these stocks reside? The Nasdaq-100 index. If you're looking for the setup for a repeat, 2026's is pretty compelling.
As far as whether a 20% correction is coming for the Nasdaq-100, it may have already started. The index is 6% below its all-time high as I write this. Technology is the worst-performing of the 11 S&P 500 sectors year to date. Given what's also happening in the crypto market right now, there definitely seems to be a risk-off sentiment that is developing.
Don't be surprised if you soon see that the Nasdaq-100 index is in bear market territory. The signs were there.
2026-02-25 03:152mo ago
2026-02-24 21:202mo ago
Coinbase Pursues ‘Everything Exchange' Concept With US Stock Trading Debut
Coinbase now offers stock trading to everyone in the United States, allowing its users to trade stocks and exchange-traded funds (ETFs) alongside the crypto the platform already handled.
This move is part of the company’s Everything Exchange vision in which it aims to encompass all asset classes and build the next generation of markets, Coinbase said in a Tuesday (Feb. 24) blog post.
Coinbase’s new stock trading offering lets users buy, sell and manage stocks and ETFs 24 hours a day, five days a week, according to the post. Users can fund their trades instantly with U.S. dollars and USDC stablecoins.
“We’re starting with the world’s leading equities and plan to expand 24/5 trading to thousands more stocks over the coming months,” Coinbase said in the post. “This spring, Coinbase also plans to broaden stock perpetuals, enabling traders outside the U.S. to get 24/7, capital-efficient exposure to U.S. equities.”
We’d love to be your preferred source for news.
Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!
Coinbase also announced in the post that it has partnered with Yahoo Finance to enable users who are researching an asset on Yahoo Finance to execute a trade on Coinbase with one click.
In addition, Yahoo Finance will incorporate real-time information from Coinbase into its site, which offers financial news, data and personal finance tools, according to the post. This integration will make it easier for users to discover and monitor assets, per the post.
Advertisement: Scroll to Continue
“This partnership ensures traders have the resources they need to thrive in an increasingly ‘always-on’ market across asset classes,” Coinbase said in the post.
Coinbase executives said during an October earnings call that the Everything Exchange concept is central to the company’s current narrative. The concept combines three layers of activity: trading, financial services and applications. The strategy aims to attract users through regulated spot and derivatives markets; retain them with financial utilities such as custody, rewards and lending; and provide infrastructure and developer tools for on-chain applications that can expand overall network demand.
During a Feb. 12 earnings call, executives highlighted the platform’s diversification plays.
“The Everything Exchange is working,” Coinbase CEO Brian Armstrong said during the call. “In 2025, we drove all-time highs across our products: Coinbase One subscriptions reached ~1 million, trading volume and market share doubled, and USDC held on platform reached an all-time high.”
2026-02-25 03:152mo ago
2026-02-24 21:222mo ago
Helix Energy Solutions: Strong Quarter And Solid Medium-Term Prospects - Buy
Helix Energy Solutions reported strong fourth quarter results, with both revenues and earnings per share coming in well above consensus expectations. Outperformance was mostly a result of strong contributions from the company's shallow water abandonment and robotics operations. HLX generated an eye-catching $107 million in free cash flow and finished the quarter with $445 million in cash and equivalents and $315 million in funded debt.
2026-02-25 03:152mo ago
2026-02-24 21:252mo ago
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
NEW YORK and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NasdaqGS: RARE) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Ultragenyx who were adversely affected by alleged securities fraud between August 3, 2023 and December 26, 2025. Follow the link below to get more information and be contacted by a member of our team:
https://www.ksfcounsel.com/cases/nasdaqgs-rare/
Ultragenyx investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-rare/ to learn more.
CASE DETAILS: On December 26, 2025, the Company announced the “results from the Phase 3 Orbit and Cosmic studies for setrusumab (UX143) in Osteogenesis Imperfecta” disclosing that both its Phase III Orbit and Cosmic studies failed to demonstrate that setrusumab triggered a statistically significant reduction in annualized fracture rates for patients with osteogenesis imperfecta, and, as a result the Company “is evaluating its planned operations and will promptly define and implement significant expense reductions.” On this news, the price of Ultragenyx’s shares fell approximately 42%, from $34.19 per share on December 26, 2025 to $19.72 per share on December 29, 2025.
The case is Steven Bailey v. Ultragenyx Pharmaceutical Inc., et al., No. 26-cv-01097.
WHAT TO DO? If you invested in Ultragenyx and suffered a loss during the relevant time frame, you have until April 6, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Varonis To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Varonis between February 4, 2025 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - February 24, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ: VRNS) and reminds investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Varonis' ability to convert its existing customer base; notably, that it was not truly equipped to convince existing users of the benefits of converting to the SaaS offering or otherwise maintain those customers on its platform, resulting in significantly reduced ARR growth potential in the near-term. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Varonis' securities at artificially inflated prices.
On October 28, 2025, Varonis announced its financial results for the third quarter of fiscal 2025, disclosing a significant miss to ARR and reducing its projections for the full fiscal year 2025, despite previously uplifting guidance for the previous two consecutive quarters. The Company attributed its results and lowered guidance on weaker than expected renewals and conversions in their federal and non-federal on-premises subscription business. Varonis further resultantly announced the end of life of the self-hosted solution and a 5% headcount reduction.
Following this news, Varonis' common stock declined dramatically. From a closing market price of $63.00 per share on October 28, 2025, Varonis' stock price fell to $32.34 per share on October 29, 2025, a decline of about 48.67% in the span of just a single day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Varonis's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Varonis Systems class action, go to www.faruqilaw.com/VRNS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/285117
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Contact Us
2026-02-25 03:152mo ago
2026-02-24 21:352mo ago
Rocket Lab Is Days From a Major Earnings Report -- and Bettors Are Quietly Getting Bullish
If the company can get its rocket of the future to an official launch, it stands to do very well indeed.
Lately, space stocks have taken off like, well, rockets. Among these, Rocket Lab (RKLB 0.47%) has done particularly well, although it's down from its peak due to a failure in late-stage testing for a crucial company asset.
The stock still has plenty of believers. Eighty percent of folks placing wagers on prediction market operator Polymarket for Rocket Lab's fourth quarter are betting on a bottom-line beat when the period's figures are released on Thursday, Feb. 26. Here's my take on whether you should go for a ride with this stock, too.
Space is the place Rocket Lab's foundational business is launch services; its Electron small-lift rocket specializes in delivering compact satellite clusters. In late 2021, sales for its space systems segment -- comprising products and services for satellite construction -- overtook those of launch services. These days, space systems is responsible for nearly three-quarters of total revenue.
Image source: Getty Images.
Yet, Rocket Lab has lofty ambitions for launch services. The company is deep in development of the Neutron, a much more powerful rocket than the Electron that, in its words, is "designed for mega constellation deployment, deep space missions, and human spaceflight."
The huge and versatile Neutron has great potential for a wide range of uses. There's a major hitch, though -- in late-stage testing last month, the craft's stage 1 fuel tank suffered a rupture. Although the so-called hydrostatic pressure qualification test was designed to subject components to near-maximum adverse conditions, the results were quite a setback.
Rocket Lab subsequently said its engineers were reviewing the trial data, adding that the craft's development would continue.
Today's Change
(
-0.47
%) $
-0.33
Current Price
$
69.88
Launch limbo Rocket Lab stated that it would supply an updated schedule on Neutron's development and -- if the coming test results are better -- eventual deployment. Its inaugural launch was most recently set for this year; it's almost certain this will be pushed back for several months at the very least.
The company has pinned much of its hope for the future of the launch services business on Neutron, so I think the market's reaction to the fourth-quarter results will depend more on that revised schedule for the rocket than the company's fundamentals. If the inaugural launch's delay doesn't stretch too far into the future (say, over a year or so), I'd expect the bulls to run free; otherwise, the stock could suffer quite a fall.
Still, it's always wise to keep an eye on a company's fundamentals. The consensus analyst estimate for fourth-quarter revenue growth is a meaty 34.6% year over year, to over $178 million. Rocket Lab is expected to post a $0.10-per-share net shortfall, in line with the year-ago result.
I'm generally bullish on this industry, despite the recent run-up in Rocket Lab and other space stocks' prices. I'd be inclined to take a flier on the stock, especially since the Neutron project has so much potential, though investing in the company remains quite speculative at present.
2026-02-25 03:152mo ago
2026-02-24 21:362mo ago
Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
NEW YORK and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Kyndryl who were adversely affected by alleged securities fraud between August 7, 2024 and February 9, 2026. Follow the link below to get more information and be contacted by a member of our team:
https://www.ksfcounsel.com/cases/nyse-kd/
Kyndryl investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850, or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-kd/ to learn more.
CASE DETAILS: On February 9, 2026, the Company disclosed that it would be unable to timely file its Form 10-Q Report for the quarter ended December 31, 2025 and that “the Company anticipates reporting material weaknesses in the Company’s internal control over financial reporting for the period covered in the Quarterly Report, as well as for the full fiscal year ended March 31, 2025, and the first two fiscal quarters of fiscal year 2026, which are expected to include, but may not be limited to, the effectiveness and strength of certain functions at the Company, including with respect to controls related to information and communication and tone at the top,” as well as the departure of its C.F.O and General Counsel. On this news, the price of Kyndryl’s shares fell $12.90 per share, or 55%, to close at $10.59 on February 9, 2026.
The case is Brander v. Kyndryl Holdings, Inc., et al., No. 26-cv-00782.
WHAT TO DO? If you invested in Kyndryl and suffered a loss during the relevant time frame, you have until April 13, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
China Yuchai International Limited (CYD) Q4 2025 Earnings Call Transcript
2026-02-25 03:152mo ago
2026-02-24 21:402mo ago
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK CITY and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Tennessee.
What You May Do
If you purchased securities of Ardent and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-ardt/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by March 9, 2026.
About the Lawsuit
Ardent and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On November 12, 2025, post-market, the Company disclosed a $43 million decrease in third quarter 2025 revenue due to revised determinations of accounts receivable collectability after the Company transitioned to a new revenue accounting system and from purported “recently completed hindsight evaluations of historical collection trends.” The Company further disclosed a cut to 2025 EBITDA guidance of $57.5 million at the midpoint, or about 9.6%, from $575 million – $625 million to $530 million – $555 million due to “persistent industry-wide cost pressures,” including “payer denials,” and also recorded a $54 million increase in professional liability reserves “with respect to recent settlements and ongoing litigation arising from a limited set of claims between 2019 and 2022 in New Mexico” as well as “consideration of broader industry trends, including social inflationary pressures.”
On this news, the price of Ardent’s shares fell $4.75 per share, or nearly 34%, from $14.05 per share on November 12, 2025, to close at $9.30 per share on November 13, 2025, on unusually heavy trading volume.
The case is Postiwala v. Ardent Health, Inc., et al., No. 26-cv-00022.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
Enphase Energy, Inc. Notice of April 20, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
NEW YORK CITY and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Enphase Energy, Inc. (“Enphase” or the “Company”) (NasdaqGM: ENPH) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Enphase who were adversely affected by alleged securities fraud between April 22, 2025 and October 28, 2025. Follow the link below to get more information and be contacted by a member of our team:
https://www.ksfcounsel.com/cases/nasdaqgm-enph/
Enphase investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgm-enph/ to learn more.
CASE DETAILS: According to the Complaint, Enphase and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company had overstated its ability to manage its channel inventory; (ii) the Company had overstated its ability to offset the impacts resulting from the termination of the Residential Clean Energy Credit pursuant to Internal Revenue Code Section 25D; and (iii) as a result, the Company overstated its financial and operational prospects.
The case is Tripathi v. Enphase Energy, Inc., No. 26-cv-01380.
WHAT TO DO? If you invested in Enphase and suffered a loss during the relevant time frame, you have until April 20, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
NEW YORK CITY and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Navan, Inc. (“Navan” or the “Company”) (NasdaqGS: NAVN) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Navan who were adversely affected if they purchased the Company’s shares pursuant and/or traceable to the Registration Statement and Prospectus (collectively, the “Offering Documents”) issued in connection with Navan’s October 2025 initial public offering (the “IPO”). Follow the link below to get more information and be contacted by a member of our team:
https://www.ksfcounsel.com/cases/nasdaqgs-navn/
Navan investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-navn/ to learn more.
CASE DETAILS: According to the Complaint, Navan and certain of its executives are charged with failing to disclose material information in the Offering Documents, violating federal securities laws. The alleged false and misleading statements and omissions include, but are not limited to, that the Company had increased its “sales and marketing” expenses for the quarter ending October 31, 2025 to nearly $95 million, or by 39% compared to $68.5 million sales and marketing expenses in the quarter ending July 31, 2025. When the true details entered the market, the lawsuit claims that the Company’s shares fell sharply.
The case is McCown v. Navan, Inc., Case No. 26-cv-01550.
WHAT TO DO? If you invested in Navan and suffered a loss during the relevant time frame, you have until April 24, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 23, 2026 to file lead plaintiff applications in a securities class action lawsuit against BellRing Brands, Inc. (NYSE: BRBR), if they purchased or otherwise acquired the Company’s securities between November 19, 2024 and August 4, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
What You May Do
If you purchased securities of BellRing and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-brbr/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by March 23, 2026.
About the Lawsuit
BellRing and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 6, 2025, the Company disclosed that “several key retailers lowered their weeks of supply on hand, which is expected to be a mid-single-digit headwind to our third quarter growth,” and that “[w]e now expect Q3 sales growth of low single digits.” On this news, the price of BellRing’s shares fell $14.88 per share, or 19%, from $78.43 per share on May 5, 2025, to close at $63.55 per share on May 6, 2025, on unusually heavy trading volume.
Then, on August 4, 2025, post-market, the Company reported its fiscal 3Q 2025 financial results, disclosing a disappointing new 2025 sales outlook, stating “BellRing management has narrowed its fiscal year 2025 outlook for net sales to [a] range between $2.28-$2.32 billion,” due to “several other competitors” gaining space to sell their products with a large retailer and that “it is not surprising to see new protein RTDs enter[ed]” the convenient nutrition market. On this news, the price of BellRing’s shares fell $17.46 per share, or nearly 33%, from $53.64 per share on August 4, 2025, to $36.18 per share on August 5, 2025, on unusually heavy trading volume.
The case is Denha v. BellRing Brands, Inc., No. 26-cv-00575.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
EBOS Group Limited (EBOSF) Q2 2026 Earnings Call February 24, 2026 5:30 PM EST
Company Participants
Martin Krauskopf - Chief Strategy & Corporate Development Officer
Adam Hall - Chief Executive Officer
Alistair Gray - Chief Financial Officer
Conference Call Participants
Matt Montgomerie - Forsyth Barr Group Ltd., Research Division
Adrian Allbon - Jarden Limited, Research Division
Stephen Hudson - Macquarie Research
Dan Hurren - MST Financial Services Pty Limited, Research Division
Stephen Ridgewell - Craigs Investment Partners Limited, Research Division
Lyanne Harrison - BofA Securities, Research Division
Saul Hadassin - Barrenjoey Markets Pty Limited, Research Division
Marcus Curley - UBS Investment Bank, Research Division
Presentation
Operator
Thank you for standing by, and welcome to the EBOS Group Limited Fiscal Year '26 Half Year Results Conference Call. [Operator Instructions] I must advise you that this conference is being recorded today, the 25th of February 2026.
I would now like to hand the call over to your first speaker today, Mr. Martin Krauskopf, Chief Strategy and Corporate Development Officer, EBOS Group. Please go ahead, Martin.
Martin Krauskopf
Chief Strategy & Corporate Development Officer
Good morning, everyone, and thank you for your attendance today. My name is Martin Krauskopf, Chief Strategy and Corporate Development Officer. I'm joined today by Adam Hall, our Group CEO; and Alistair Gray, our Group CFO.
Before commencing, I'd like to draw your attention to the disclaimer on Page 2 of the presentation. The results are expressed in Australian dollars, unless otherwise noted, and the presentation refers to both statutory and underlying results. The commentary this morning is predominantly based on our underlying results, and a reconciliation is included in the appendix.
I'll now hand over to Adam to take you through today's presentation.
Adam Hall
Chief Executive Officer
Thank you, Martin. I'm pleased to walk you through EBOS Group's half year '26 results and the momentum we're building
Growthpoint Properties Australia Stapled Securities (GRWPF) Q2 2026 Earnings Call February 24, 2026 7:01 PM EST
Company Participants
Ross Lees - CEO, MD & Director
Nick Kost - Group Executive & Head of Property
Conference Call Participants
Adam West - JPMorgan Chase & Co, Research Division
Elizabeth Andre - Macquarie Research
Presentation
Operator
Thank you for standing by, and welcome to the Growthpoint Properties Australia 1H '26 Results Call. [Operator Instructions] I would now like to hand the conference over to Mr. Ross Lees, Chief Executive Officer and Managing Director. Please go ahead.
Ross Lees
CEO, MD & Director
Good morning. My name is Ross Lees, Chief Executive Officer and Managing Director of Growthpoint Properties Australia, and I welcome you to the presentation of our half year '26 results. I would like to begin today by acknowledging the traditional owners of country throughout Australia and their enduring connections to land, sea and community. Today, we join you from the traditional land of the Wurundjeri people of the Kulin Nation, and we pay our respects to elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people joining us today.
Presenting alongside me today is Nick Kost, our Head of Property, who has recently joined the executive team after leading the Growthpoint Property team for the last 5 years. I'm also joined in the room by Jacquee Jovanovski, our COO; and Alix Holston, our Head of Investor Relations.
Before we move to the results, I would like to provide a short overview of Growthpoint today. Our purpose, creating value beyond real estate anchors everything we do. We combine active management of high-quality Australian real estate with long-standing tenant and investor partnerships and disciplined capital management. Today, we manage $4.1 billion of directly held assets, which underpin our income-driven returns and $1.4 billion managed on behalf
2026-02-25 03:152mo ago
2026-02-24 21:482mo ago
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK, and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until April 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Corcept Therapeutics Incorporated (NasdaqCM: CORT) (“Corcept” or the “Company”), if they purchased or otherwise acquired the Company’s shares between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
What You May Do
If you purchased shares of Corcept and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqcm-cort/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by April 21, 2026.
About the Lawsuit
Corcept and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The complaint alleges that, during the Class Period, the Company represented to investors that there was a high likelihood that one of its lead new product candidates, relacorilant, would receive approval from the U.S. Food and Drug Administration (“FDA”) after the Company’s New Drug Application (“NDA”) submission. However, on December 31, 2025, the Company disclosed that the FDA had issued a Complete Response Letter (“CRL”) regarding the NDA for relacorilant and that it had “concluded it could not arrive at a favorable benefit-risk assessment for relacorilant without Corcept providing additional evidence of effectiveness.”
On this news, the price of Corcept’s shares plummeted by $35.40 per share, or 50.4%, from a closing price of $70.20 on December 30, 2025, to a closing price of $34.80 on December 31, 2025.
The case is Allegheny County Employees’ Retirement System v. Corcept Therapeutics Incorporated, No. 26-cv-01525.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
by Kurt Schlosser on Feb 24, 2026 at 6:54 pmFebruary 24, 2026 at 6:55 pm
The front lobby of Kumo, an Amazon office building at 1915 Terry Ave. in Seattle. (GeekWire Photo / Taylor Soper) Amazon plans to exit an office building near its Seattle headquarters, 12 years after taking over the space during the height of its growth in the city.
Amazon is not renewing its lease at 1915 Terry Ave. in the Denny Triangle area of downtown Seattle, the company confirmed to GeekWire on Tuesday. The tech giant, which has occupied the seven-story, 251,000-square-foot space owned by Seattle Children’s since 2014, will move out at the end of May and relocate employees to other offices.
The Puget Sound Business Journal first reported on the planned move.
The seven-story building in the Denny Triangle neighborhood is owned by Seattle Children’s. (GeekWire Photo / Taylor Soper) Kumo, as Amazon calls it, is a 1950s-era building located just a few blocks from Amazon’s main office towers and the Spheres. Amazon did not say how many employees work from the building.
The company employs approximately 50,000 corporate and tech employees in Seattle. More than 1,400 workers in Seattle were impacted by company-wide layoffs of 16,000 people announced at the end of January.
PSBJ reported that since 2020, Amazon has given up more than 1 million square feet of office space in Seattle, most of it in the Denny Triangle.
The company has been growing its footprint across Lake Washington in Bellevue, where it has opened new office buildings and said it plans to employ 25,000 people as part of its regional HQ.
2026-02-25 03:152mo ago
2026-02-24 21:552mo ago
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK CITY and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until April 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against uniQure N.V. (NasdaqGS: QURE) (“uniQure” or the “Company”), if they purchased or otherwise acquired the Company’s shares between September 24, 2025 and October 31, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
What You May Do
If you purchased shares of uniQure and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-qure/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by April 13, 2026.
About the Lawsuit
uniQure and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
During the Class Period, the Company represented to investors that there was a high likelihood that its leading drug candidate, AMT-130, would receive accelerated approval from the U.S. Food and Drug Administration (“FDA”) after the Company’s planned Biologics License Application (“BLA”) submission in the first quarter of 2026. However, on November 3, 2025, the Company disclosed that “the FDA currently no longer agrees that the data from the Phase I/II studies of AMT-130 in comparison to an external control, as per the prespecified protocols and statistical analysis plans shared with the FDA in advance of the analyses, may be adequate to provide the primary evidence in support of a BLA submission” and as a result, “the timing of the BLA submission for AMT-130 is now unclear.”
On this news, the price of uniQure’s shares plummeted $33.40 per share, or more than 49%, from a close of $67.69 per share on October 31, 2025, to close at $34.29 per share on November 3, 2025.
The case is Scocco v. uniQure N.V., et al., Case No. 1:26-cv-01124.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
Zeta Global Holdings Corp. (ZETA) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST
Company Participants
Matthew Pfau - Senior Vice President of Investor Relations
David Steinberg - Co-Founder, Chairman of the Board & CEO
Christopher Greiner - Chief Financial Officer
Conference Call Participants
Terrell Tillman - Truist Securities, Inc., Research Division
Zach Cummins - B. Riley Securities, Inc., Research Division
Jason Kreyer - Craig-Hallum Capital Group LLC, Research Division
Arjun Bhatia - William Blair & Company L.L.C., Research Division
David Hynes - Canaccord Genuity Corp., Research Division
Richard Baldry - ROTH Capital Partners, LLC, Research Division
Kathleen Alexis Keyser - Morgan Stanley, Research Division
Matthew Swanson - RBC Capital Markets, Research Division
Jackson Nichols - KeyBanc Capital Markets Inc., Research Division
George McGreehan - BofA Securities, Research Division
Carolyn Valenti - Goldman Sachs Group, Inc., Research Division
Presentation
Operator
Greetings, and welcome to the Zeta Q4 2025 Earnings Conference Call. [Operator Instructions] Please note this conference is being recorded.
I will now turn the conference over to your host, Matt Pfau. Thank you. You may begin.
Matthew Pfau
Senior Vice President of Investor Relations
Thank you, operator. Hello, everyone, and thank you for joining us for Zeta's Fourth Quarter 2025 Conference Call. Today's presentation and earnings release are available on Zeta's Investor Relations website at investors.zetaglobal.com, where you will also find links to our SEC filings, along with other information about Zeta.
Joining me on the call today are David Steinberg, Zeta's Co-Founder, Chairman and Chief Executive Officer; and Chris Greiner, Zeta's Chief Financial Officer.
Before we begin, I'd like to remind everyone that statements made on this call as well as in the presentation and earnings release contain forward-looking statements regarding our financial outlook, business plans and objectives and other future events and developments, including statements about the market potential of our products, potential competition, revenues of our products and our goals
2026-02-25 03:152mo ago
2026-02-24 22:022mo ago
Mercado Libre Says AI Investments Support 45% Revenue Surge
Mercado Libre’s application of artificial intelligence across its online commerce ecosystem added revenue and enhanced efficiency in the fourth quarter, the company said Tuesday (Feb. 24).
Mercado Libre Chief Financial Officer Martín de los Santos led off an earnings call by saying that the company recorded fourth quarter net revenues growth of 45% year over year, supported by the acceleration of its commerce business and the rapid expansion of its FinTech services.
“Crucially, both of these are increasingly supported by the tangible impact of our investments in artificial intelligence,” de los Santos said.
Mercado Libre’s online commerce ecosystem, which serves 18 countries in Latin America, includes an eCommerce platform and a FinTech platform called Mercado Pago that offers digital accounts to individuals as well as accounts and payment processing services to merchants.
In its commerce business, Mercado Libre saw 67% year-over-year growth in the advertising business in the fourth quarter, which it attributed to AI-powered bidding algorithms and automated campaign tools, according to a Tuesday earnings release.
We’d love to be your preferred source for news.
Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!
The company also achieved higher total payment value (TPV) per merchant and shortened payback periods by deploying AI tools in acquiring, according to the release. With these tools, it was better able to identify high-value merchants, per the release.
Advertisement: Scroll to Continue
Mercado Libre added AI tools for both buyers and sellers to its marketplace, it said in a Tuesday letter to shareholders.
For buyers, it launched an AI-enhanced search experience in Argentina that personalizes search results based on each buyer’s search and transaction history. For example, using this data, it will display the buyer’s preferred brands or their choice of value options or premium options.
For sellers, the marketplace includes a Seller Assistant that facilitates onboarding, offers recommendations to improve listing quality, creates short-form videos from a single product image and handles customer service inquiries.
“These initiatives are early steps in a broader effort to embed AI across the marketplace to improve discovery, increase relevance and conversion and deepen engagement,” the company said in the letter.
In the FinTech business, the company launched a Mercado Pago AI Assistant in October, according to the earnings release. During the fourth quarter, the AI assistant handled more than 9 million customer inquiries, 87% of which it was able to handle without the support of human operators, according to the release.
“There are dozens of use cases, including general inquiries, making transfers and paying bills, and in the coming months, we plan to expand the Assistant’s capabilities to make it increasingly proactive,” Mercado Libre said in the letter to shareholders.
2026-02-25 03:152mo ago
2026-02-24 22:072mo ago
Globus Medical, Inc. (GMED) Q4 2025 Earnings Call Transcript
Palantir is structurally advantaged in data-centric defense and regulated enterprise markets, with FY25 revenue of $4.475B, 954 customers, and no >10% customer concentration, supporting durable operational relevance. Stock is ~35% off highs with weak technicals, trading ~100x FY26 EPS and ~60% above sector PEG median; valuation implies negative margin of safety despite long-term compounding tailwinds. Likely outcome is sideways trading in price as earnings catch up; watch $326.1M investee contracts, $4.1B backlog strength, cancellation clauses, and U.S. budget delays that can disrupt revenue timing.
2026-02-25 02:152mo ago
2026-02-24 19:412mo ago
New Data Shows Which US Investors Actually Sold Bitcoin ETFs
New Data Shows Which US Investors Actually Sold Bitcoin ETFs Prefer us on Google
US institutions cut Bitcoin ETF exposure by ~25,000 BTC in Q4 2025, led by advisors and hedge funds.13F filings show reduced ETF positions, which can translate into real selling pressure on Bitcoin.Overall institutional exposure declined, reinforcing Bitcoin’s current correction trend.Large US investors reduced their Bitcoin ETF holdings in late 2025, and new breakdowns show the selling came mainly from a few specific groups rather than the entire market.
Bloomberg Intelligence data shared by analysts shows that 13F filers — large institutions that report quarterly holdings to the US SEC — were net sellers of Bitcoin ETFs in Q4 2025, cutting exposure by nearly $1.6 billion.
What did 13F filers do with the Bitcoin ETFs in Q4??
In what should not be much of a surprise — they were sellers. Advisors and Hedge Funds (the two largest holder categories) were the biggest sellers. Overall 13F Filers sold ETF shares equivalent to ~25,000 Bitcoin in 4Q 2025. pic.twitter.com/0MEbzXVDb1
— James Seyffart (@JSeyff) February 24, 2026 The biggest reductions came from investment advisors and hedge funds, the two largest holder categories.
A 13F filer is a large US money manager (usually with over $100 million in qualifying assets) that must report its holdings every quarter. These filings show a snapshot of positions at quarter-end.
These firm’s reported Bitcoin ETF holdings were lower in Q4 than in Q3. In other words, they reduced ETF shares, not necessarily that they sold physical Bitcoin directly on exchanges.
US Bitcoin ETF Inflow and Outflow in 2026. Source: SoSoValueThat helps explain why Bitcoin has remained under pressure even during short-term rebounds. ETF flow data shows repeated daily outflows in recent weeks, including several large red days in February.
Who Sold the MostThe category-level data shows the largest net reductions came from:
Investment Advisors: about -21,831 BTC Hedge Fund Managers: about -7,694 BTC Other categories, such as brokerages and banks also reduced exposure.
However, some groups increased holdings, including holding companies and government-related entities.
Bitcoin Price Chart Over the Past Month: Source: CoinGeckoThis does not mean “all institutions turned bearish.” Many firms use Bitcoin ETFs for hedging, arbitrage, or short-term trading, not just long-term bets.
However, the broader signal is clear. Big-money positioning weakened, and that matches the recent ETF outflow trend.
Until daily ETF flows stabilize and turn positive for more than a few sessions, Bitcoin may remain in a fragile, relief-rally phase rather than a full recovery.
Disclaimer
In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.
2026-02-25 02:152mo ago
2026-02-24 20:002mo ago
XRP At Risk? Large Holders Stir The Market, Increasing Near-Term Turbulence
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure
The broader cryptocurrency market saw a sharp drop today, and the price of XRP took a big hit, falling to the $1.35 level. After a period of downside action, current on-chain activity is weakening, which is hinting at a continuation of the current bearish environment for the leading altcoin.
A Spike In XRP Whale Transfers XRP’s price is facing heightened bearish pressure following a sharp market pullback on Monday, capping its upward attempts. In the meantime, the activity of large holders is once again drawing attention to the altcoin’s short-term price outlook.
According to a verified CryptoQuant author and analyst, Darkfost, these investors’ activity currently raises short-term risk for the altcoin as data shows a noticeable uptick in whale transactions and sizable wallet movements. Significant capital repositioning by major holders frequently precedes times of increased volatility, particularly in a market already dealing with brittle sentiment.
Darkfost has mainly attributed the ongoing waning of investors’ performance to Bitcoin’s sideways price action. BTC continues to range, triggering limited directional clarity in the short term. This lack of momentum is putting pressure on the broader market, with altcoins like XRP persistently underperforming in the absence of a clear trend.
In addition, this week was notably marked by a significant inflow of the token to the world’s largest cryptocurrency exchange, Binance. Since the market turned extremely bearish, the platform has remained the go-to exchange for large transactions due to its robust liquidity.
Source: Chart from Darkfost on X Looking at the data from the chart, more than 31 million XRP were seen being moved to the exchange in a single day, particularly on Sunday. Interestingly, these inflows were primarily spearheaded by activity from the largest investor group.
Wallet addresses holding less than 1,000 XRP and 1,000 to 10,000 holders sent 6,543 and 73,630 of the token, respectively, to Binance. 10,000 to 100,000 holders transferred 2,938,809, those holding between 100,000 and 1 million move 14,236,825, and those above 1 million sent 14,494,865 XRP to the Binance platform.
When taken as a whole, this indicates a sudden potential sell-side pressure of about $45 million that needs to be closely watched. Should this selling pressure persist, the expert believes that the altcoin may struggle to recover from its ongoing correction in the near term.
Spot ETFs Have Not Lost Their Momentum Yet Even in a volatile environment, the XRP Spot Exchange-Traded Funds (ETFs) are still displaying momentum. Xaif Crypto, a market expert, shared on X that the newly launched funds are quietly stacking, suggesting underlying strength and confidence.
Over the past 3 months alone, Bitwise added more than $258.97 million of XRP, Franklin Templeton recorded over $329.86 million, and Canary Capital saw inflows of over $105.32 million. While the price seems uninteresting, hundreds of millions are pouring into the altcoin’s exposure. Currently, smart money is positioning early, and this activity could play a role in shaping the altcoin’s next price trajectory.
XRP trading at $1.32 on the 1D chart | Source: XRPUSDT on Tradingview.com Featured image from Pngtree, chart from Tradingview.com
Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.
Bitcoin hit $63,000 this Tuesday, a critical threshold that has many in the crypto world panicking. Analysts are already sounding the alarm, fearing this could be just the beginning of an even more severe decline.
Jean Dupont from CryptoMarket Insights isn’t mincing words. “We could see Bitcoin drop to $47,000 soon,” he says bluntly. This does little to reassure investors who are watching their portfolios melt away. Last October, Bitcoin was trading at $126,000. Today, its value has been halved. Tightening regulations in China and speculation about interest rate hikes in the United States are piling up, creating enormous pressure on prices.
Not exactly a laughing matter.
Trading platforms are seeing volumes explode, a sign that anxiety is spreading. Many Bitcoin holders are selling to limit their losses. Kraken reported a 25% increase in volumes compared to last week. Isabelle Martin, the CEO, doesn’t hold back: “Investors need to stay vigilant.” Volatility remains at crazy levels, and no one really knows where it will stop. As for financial authorities, there’s radio silence for now. The U.S. SEC has yet to lift a finger to comment on the current state of the crypto market.
The result: uncertainty reigns.
And while Bitcoin is plummeting, investors are flocking to safe havens. Gold and bonds are back in vogue. Diversification strategies, which had been somewhat forgotten, are back in the spotlight. But not everyone sees things in a negative light. Some experts actually smell a good deal. For them, these fluctuations merely reflect the volatile nature of Bitcoin, nothing more.
Ethereum isn’t escaping the turmoil, losing 15% in a week. Investors are worried about the repercussions on the entire crypto market. On February 23, Chainalysis published a chilling report. Suspicious transactions have jumped 30% compared to the previous month. This could well exacerbate current volatility, according to the report. This follows earlier reporting on Bitcoin Crashes Below ,000 as Trump.
Binance has temporarily suspended Bitcoin withdrawals. Changpeng Zhao, the CEO, says it’s due to high volatility. “We want to protect our users,” he explains in a statement. A measure that clearly shows the extent of the panic.
Ark Invest, Cathie Wood’s fund, remains confident nonetheless. The fund continues to accumulate digital assets. “We see this as a buying opportunity,” Wood said at a press conference on February 22. Not everyone shares her optimism, though.
BlackRock is closely monitoring the situation. Larry Fink thinks the current volatility could offer long-term buying opportunities for savvy investors. A statement that is causing a stir in financial circles. JPMorgan issued an internal note that’s less dreamy. According to the bank, Bitcoin could reach a critical point if the $60,000 support level fails. Analysts believe that selling pressure could intensify in the coming days.
Economist Nouriel Roubini isn’t holding back. At a conference in London on February 23, he called the situation a “speculative bubble.” He warns that the market could undergo significant corrections affecting not just Bitcoin but all digital assets.
George Soros’s Quantum Fund is adjusting its strategy and reducing its Bitcoin exposure. A spokesperson confirmed this change on February 24, citing a more cautious approach in the face of uncertainty. Coinbase sees its sign-ups surge by 40%. Brian Armstrong, the CEO, believes this is linked to interest in bargain buying opportunities. “We are observing an interesting dynamic among individual investors,” he says. For more details, see Bitcoin Drops Below Key Support as.
Fidelity is strengthening its monitoring of digital assets. Tom Jessop, president of Fidelity Digital Assets, said during a conference call that the current volatility requires heightened vigilance. “We remain committed but cautious,” he notes. Goldman Sachs points out that the correlation between Bitcoin and traditional stock markets is increasing. Analysts think this could influence decisions by investors looking to diversify their portfolios.
CME Group has recorded a 30% increase in Bitcoin futures contracts compared to the previous week. Terry Duffy, the president, says this reflects continued demand for cryptocurrency-related derivatives.
European central banks have been closely watching Bitcoin’s movements since their February meeting. The European Central Bank has intensified its monitoring of capital flows into cryptocurrencies, fearing repercussions on traditional financial stability. Christine Lagarde had warned of systemic risks a few weeks ago.
MicroStrategy, one of the largest institutional holders of Bitcoin with nearly 130,000 bitcoins in its portfolio, sees its valuation mechanically drop. Michael Saylor is sticking to his accumulation strategy, but shareholders are starting to grumble over latent losses now amounting to billions of dollars.
Post Views: 3
2026-02-25 02:152mo ago
2026-02-24 20:302mo ago
Stripe Eyes Potential PayPal Acquisition as Stablecoin Competition Heats Up
Stripe is reportedly exploring a potential acquisition of all or parts of PayPal (NASDAQ: PYPL), according to a recent Bloomberg report. While discussions remain in the early stages, a deal would unite two global payments giants that have increasingly expanded into the cryptocurrency and stablecoin markets.
Stripe processed approximately $1.9 trillion in transactions last year and was recently valued at $159 billion, underscoring its growing dominance in digital payments. Acquiring PayPal could significantly strengthen Stripe’s position in both traditional online payments and blockchain-based financial services.
A merger would also deepen Stripe’s footprint in the fast-growing stablecoin sector. PayPal launched its U.S. dollar-backed stablecoin, PYUSD, in partnership with Paxos in 2022. Since its debut, PYUSD has grown to a market capitalization of around $4 billion. The stablecoin enables users to transfer U.S. dollars across crypto networks 24/7, often at lower costs compared to traditional bank wire transfers, positioning PayPal as a serious player in crypto payments.
Stripe has also accelerated its crypto strategy. In 2024, the company acquired Bridge for $1.1 billion, a platform that helps businesses and blockchain projects issue dollar-backed tokens. Additionally, Stripe is collaborating with venture capital firm Paradigm to develop Tempo, a payments-focused blockchain currently in testing. These initiatives highlight Stripe’s long-term commitment to integrating stablecoins and blockchain technology into mainstream financial infrastructure.
Meanwhile, PayPal has faced significant financial challenges. Its stock price has fallen roughly 80% from its 2021 peak, reflecting slowing growth and increased competition in the digital payments industry. However, shares have recently gained momentum amid acquisition speculation, rising 7% following reports of Stripe’s interest.
If completed, a Stripe-PayPal deal could reshape the global payments landscape, intensify competition in the stablecoin market, and accelerate the convergence of traditional finance and cryptocurrency.
<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>
2026-02-25 02:152mo ago
2026-02-24 20:442mo ago
XRP Price Nears Key Support as Double Bottom Zone Comes Back Into Focus
XRP is approaching a critical support level that previously formed a double bottom in early 2026, placing the cryptocurrency at a potentially निर्णing point. After weeks of sustained downside pressure and a clear bearish trend, XRP price action is once again testing a historical reaction zone that could attract renewed buying interest. While there is no confirmed reversal signal yet, the proximity to this level makes the coming trading sessions especially important for XRP’s short-term outlook.
From a technical analysis perspective, XRP remains under significant pressure. The chart structure continues to show lower highs and lower lows, confirming bearish market dominance. In addition, the price is trading below key moving averages, reinforcing the broader downtrend. As long as XRP remains under these technical barriers, sellers maintain control of the market.
However, crypto markets rarely move in a straight line. Strong historical support zones often act as areas where bearish momentum begins to slow. The current level is particularly important because it previously triggered a double bottom pattern, which marked temporary selling exhaustion and led to a short-term rebound. If XRP stabilizes near this support again, traders could see a similar base-building process unfold.
That said, support alone does not guarantee a reversal. A double bottom pattern only becomes meaningful if buyers step in decisively and defend the lows. Without strong demand and sustained price stability above this zone, XRP could break below support and extend its losses further.
For now, market participants should closely monitor price behavior around this key level. If XRP consolidates and forms a new base, it could signal the beginning of stabilization. Otherwise, a breakdown may confirm continued bearish momentum in the broader cryptocurrency market.
<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>
Bitcoin has fallen below the crucial $63,000 level, a move that carries major psychological and technical implications for the cryptocurrency market. This breakdown suggests that the recent consolidation phase failed to deliver the stability many traders anticipated. Instead of forming a strong base, Bitcoin’s price action now reflects continued bearish pressure, raising concerns about further downside risk.
The drop below $62,720 is particularly significant because this zone had served as a key short-term support level after weeks of heightened volatility. Analysts had been watching for the formation of a tightening price structure, which could have indicated stabilization and renewed buying interest. However, that attempt failed, highlighting weakening demand and growing seller dominance.
In technical analysis, consecutive support breaks often shift market sentiment from hesitation to continuation. With Bitcoin losing the low-$60,000 range, sellers appear to be regaining control. This level had acted as a final defensive line for bulls, and its loss places the market in a more vulnerable position. If buyers cannot quickly reclaim this zone, bearish momentum could accelerate.
The broader cryptocurrency market typically reacts strongly when Bitcoin breaches major psychological thresholds. As the largest digital asset by market capitalization, Bitcoin often dictates overall crypto sentiment. A sustained move lower could trigger additional selling pressure as traders reassess short-term risk exposure and adjust their positions.
At the moment, there is limited strong support directly below the current price, increasing the risk of further downside. While the breakdown below $63,000 does not automatically signal a market collapse, it does push Bitcoin into a higher-risk environment. Unless buyers step in decisively to stabilize the price and rebuild confidence, the next phase of the market cycle could involve a deeper correction, keeping investors on edge.
<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>
2026-02-25 02:152mo ago
2026-02-24 20:552mo ago
Bitcoin, Ethereum, XRP, Dogecoin Recover But 'Extreme Fear' Sentiment Lingers: Analyst Says Markets Will Remain 'Boring' Until This Day
Leading cryptocurrencies rallied in tandem with stocks on Tuesday, even as tariff uncertainty and geopolitical tensions weighed on the market. Cryptocurrency 24-Hour Gains +/- Price (Recorded at 8:30 p.m.
2026-02-25 02:152mo ago
2026-02-24 20:572mo ago
Sui Price Eyes Rebound as Third Spot SUI ETF Launches on Nasdaq
Sui (SUI) price is attempting to rebound after the launch of the third spot SUI ETF on Nasdaq, even as the broader cryptocurrency market remains under pressure. Over the past week, SUI has declined nearly 10%, slipping below the crucial $1 level amid continued selling across major digital assets such as Bitcoin, Ethereum, Solana, and Dogecoin. Despite the recent downturn, short-term technical indicators suggest that sentiment could improve in the near term.
The U.S. Securities and Exchange Commission has officially approved the 21Shares Spot SUI ETF, which now trades on Nasdaq under the ticker TSUI. The fund carries a 0.30% management fee and provides investors with regulated, direct spot exposure to Sui without requiring them to hold tokens in personal wallets. This marks the third SUI-focused exchange-traded fund in the U.S. market, following earlier launches by Grayscale and Canary Capital. 21Shares also recently introduced a staked SUI ETF, expanding access to Sui through traditional brokerage accounts.
Although the ETF approval is a significant milestone for institutional adoption, SUI price continues to hover around key support levels due to market volatility and profit-taking. Analysts are closely monitoring ETF trading volumes and fund inflows to assess whether sustained institutional demand can boost liquidity and drive long-term price growth.
Adding to market dynamics, SUI leads upcoming token unlocks. According to CryptoRank, approximately 48.87 million SUI tokens—around 0.54% of total supply—are scheduled for release on March 1. Large token unlocks can increase short-term selling pressure, which traders are factoring into price forecasts.
Currently trading near $0.86, SUI faces resistance around $0.90. Technical indicators such as the MACD remain bearish, while the RSI near 34 signals oversold conditions. Immediate support lies at $0.80, with downside risks toward $0.70 and $0.65 if that level breaks. A decisive move above $0.90 could open the path to $1.00, followed by $1.20 and potentially $1.50 if bullish momentum strengthens.
<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>
2026-02-25 02:152mo ago
2026-02-24 20:592mo ago
Cardano Price Eyes $0.30 as Whales Accumulate 819M ADA During Market Dip
Cardano price hovered around $0.26 on Wednesday, hinting at a potential rebound despite ongoing volatility in the broader crypto market. After a minor pullback, ADA posted a modest recovery in recent hours, with traders closely watching key resistance levels. While the token has declined nearly 7% over the past week amid renewed concerns surrounding US tariff developments, on-chain data suggests strong accumulation by large holders.
According to insights from Santiment, whales have accumulated approximately 819 million ADA during the recent dip. Over the past six months, Cardano has fallen significantly from $0.90 to around $0.26. Despite this decline, wallets holding between 100,000 and 100 million ADA have steadily increased their positions. These large investors added roughly 213.9 million ADA in net accumulation, representing about 1.6% of the total supply. Their overall holdings rose from 66.84% to 68.44% of circulating supply, bringing the group’s total to nearly 25.35 billion ADA. This growing supply concentration signals rising confidence among major investors as ADA trades near multi-month lows.
From a technical perspective, Cardano price action remains under short-term pressure but shows early signs of stabilization. ADA continues to hold above the $0.25 support level, with buyers defending this zone on moderate volume. The MACD indicator recently formed a minor bearish crossover, reflecting weak momentum and lingering seller control. Although histogram bars are gradually improving, they remain in negative territory, suggesting only a slow shift in sentiment rather than a confirmed trend reversal.
The Chaikin Money Flow indicator also remains below zero, pointing to continued capital outflows. However, if ADA breaks above $0.27, it could retest $0.28, a key psychological level. A sustained move beyond $0.28 may open the door toward the crucial $0.30 resistance. Conversely, a drop below $0.25 could push Cardano price toward the next support at $0.24, which may determine the token’s near-term direction.
<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>
2026-02-25 02:152mo ago
2026-02-24 21:002mo ago
Will Espresso [ESP] hit $1B valuation? Korean listings spark 80% explosion
On the 24th of February, Espresso dominated headlines with raw momentum. The project operated as a shared sequencing layer for Ethereum Layer-2 rollups. That infrastructure narrative suddenly met aggressive capital inflows.
Notably, Binance and Coinbase had listed ESP on the 12th of February. However, Upbit and Bithumb listings shifted sentiment violently. Korean liquidity poured in fast. Could this wave sustain the breakout?
ESP up 80% in 24 hours, hitting $0.173 The move was sharp and relentless. Espresso [ESP] surged 80% within a single day, trading at $0.173 at press time. It outperformed a sluggish broader market without hesitation, leaving most altcoins behind.
Source: CoinMarketcap
Due to these developments, the price entered clean discovery territory. There was no historical resistance capping momentum.
Therefore, traders chased upside aggressively, fearing a missed opportunity. At the time of writing, the token was in a violent expansion phase, beating nearly every major token across the board.
Volume explodes and Open Interest hits all-time highs The breakout was backed by undeniable participation. Volume exploded to $881M, according to CoinGlass data.
Source: CoinGlass
That number alone reflected intense speculative and spot demand, and it was exactly what investors wanted to see during a breakout of this scale. This was not thin liquidity or random retail noise. It showed real commitment and full conviction flowing into the market.
Meanwhile, Open Interest climbed to $56.03M at press time.
Source: CoinGlass
Fresh leverage entered quickly as traders positioned for continuation. These were not just small investors testing the waters. As a result, volatility risk increased alongside conviction, with serious capital now exposed to sharp swings.
Is this the start of a run to a $1B valuation? Major Korean listings historically fueled extended rallies. In particular, Upbit access often amplified aggressive retail-driven expansion cycles. Also, Binance, the beast of liquidity, thanks to its deep liquidity, provided the structural backbone for sustained trading activity. This suggested the rally carried more than hype.
It carried access, reach, and serious market depth.
Moreover, $881M in Volume signaled undeniable capital rotation.
That level alone reflected intensity approaching billion-dollar territory. Therefore, a $1B valuation no longer seemed distant; it felt increasingly achievable under sustained pressure.
However, failure to sustain leverage could unwind gains sharply and brutally. Looking ahead, continuation required stable demand, disciplined positioning, and consistent liquidity support.
Final Summary Espresso [ESP] surged 80% in 24 hours, trading at $0.173 after aggressive capital inflows. Korean exchange listings on Upbit and Bithumb triggered a sharp sentiment shift and liquidity spike.